C urrently, Ozempic is only approved to treat type 2 diabetes. But in recent years, the semaglutide injection has become a ...

I nterest in the weight loss drug Saxenda has skyrocketed. According to Google Trends, searches have increased by a staggering 141 per cent over the past 12 months with many clamouring to get hold ...

Trish Webster died of acute gastrointestinal illness after several months of taking Ozempic and Saxenda Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

Novo Nordisk became only the eighth company to be suspended from the ABPI in its 40-year history for several transgressions, the most serious of which was a breach of Clause 2 of the code, deemed to ...

It’s also available as the brand-name injection Saxenda, which is approved for weight loss. Victoza has a boxed warning. A boxed warning is the most serious warning from the Food and Drug ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British ...

The study used the company's older GLP-1 agonist therapy Saxenda (liraglutide), which requires a daily injection, rather than its top-selling once-weekly obesity drug Wegovy (semaglutide), and ...

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out of pocket, GoodRx said.

This opens the door to the possibility of Lexaria developing and selling the world's first oral capsule or tablet version of ... the DehydraTECH-processing of Saxenda® to the conventional ...